Clinical Trials · NCT01006954

Outcome of Two Protocols in Poor Responders in Assisted Reproductive Technology (ART) Cycle

CompletedPhase 3Gonadorelin (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Royan Institute
Enrollment
200
Start date
Sep 2008
Locations
1 site, Iran
Primary endpoint
Live birth rate
View Gonadorelin compound reference